Zubin Bhagwagar

Zubin Bhagwagar is a distinguished professional in the field of psychiatry and neuroscience, currently serving as the VP of External Innovation at Intra-Cellular Therapies since 2023 and an adjunct Associate Professor of Psychiatry at Yale University School of Medicine since 2005. Bhagwagar has extensive experience in both academic and industry settings, previously holding positions such as Chief Medical Officer for a biotech company in stealth, Entrepreneur in Residence at the University of Connecticut, and SVP at Rallybio, where focus was on R&D for rare diseases. A former Vice President at Alexion Pharmaceuticals, Bhagwagar led initiatives for external innovation and strategic partnerships, and as Group Director at Bristol-Myers Squibb, played a crucial role in early clinical development in oncology and neuroscience. Education includes a DPhil from the University of Oxford, along with medical degrees from Delhi University. Bhagwagar has received multiple grants from NIH and various foundations for research on the neurobiology of mood disorders, leveraging advanced neuroimaging techniques.